These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37078237)

  • 1. New insights into the pathophysiology of methylmalonic acidemia.
    Head PE; Meier JL; Venditti CP
    J Inherit Metab Dis; 2023 May; 46(3):436-449. PubMed ID: 37078237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin.
    Head PE; Myung S; Chen Y; Schneller JL; Wang C; Duncan N; Hoffman P; Chang D; Gebremariam A; Gucek M; Manoli I; Venditti CP
    Sci Transl Med; 2022 May; 14(646):eabn4772. PubMed ID: 35613279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
    Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
    Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
    Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
    Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
    Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
    Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metabolic disorders using genomic technologies: Lessons from methylmalonic acidemia.
    Venturoni LE; Venditti CP
    J Inherit Metab Dis; 2022 Sep; 45(5):872-888. PubMed ID: 35766386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia.
    Manoli I; Gebremariam A; McCoy S; Pass AR; Gagné J; Hall C; Ferry S; Van Ryzin C; Sloan JL; Sacchetti E; Catesini G; Rizzo C; Martinelli D; Spada M; Dionisi-Vici C; Venditti CP
    J Inherit Metab Dis; 2023 Jul; 46(4):554-572. PubMed ID: 37243446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
    Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
    Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia.
    An D; Schneller JL; Frassetto A; Liang S; Zhu X; Park JS; Theisen M; Hong SJ; Zhou J; Rajendran R; Levy B; Howell R; Besin G; Presnyak V; Sabnis S; Murphy-Benenato KE; Kumarasinghe ES; Salerno T; Mihai C; Lukacs CM; Chandler RJ; Guey LT; Venditti CP; Martini PGV
    Cell Rep; 2017 Dec; 21(12):3548-3558. PubMed ID: 29262333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing.
    Venturoni LE; Chandler RJ; Liao J; Hoffmann V; Ramesh N; Gordo S; Chau N; Venditti CP
    Mol Genet Metab; 2022; 137(1-2):1-8. PubMed ID: 35868241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics studies in cellular models of methylmalonic acidemia and propionic acidemia reveal dysregulation of serine metabolism.
    Anzmann AF; Pinto S; Busa V; Carlson J; McRitchie S; Sumner S; Pandey A; Vernon HJ
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165538. PubMed ID: 31449969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.
    Chandler RJ; Venditti CP
    Mol Ther; 2010 Jan; 18(1):11-6. PubMed ID: 19861951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylmalonic acidemia (MMA).
    Tanpaiboon P
    Mol Genet Metab; 2005 May; 85(1):2-6. PubMed ID: 15959932
    [No Abstract]   [Full Text] [Related]  

  • 15. TAT-MTS-MCM fusion proteins reduce MMA levels and improve mitochondrial activity and liver function in MCM-deficient cells.
    Erlich-Hadad T; Hadad R; Feldman A; Greif H; Lictenstein M; Lorberboum-Galski H
    J Cell Mol Med; 2018 Mar; 22(3):1601-1613. PubMed ID: 29265583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies.
    Haijes HA; van Hasselt PM; Jans JJM; Verhoeven-Duif NM
    J Inherit Metab Dis; 2019 Sep; 42(5):745-761. PubMed ID: 31119742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.
    Chandler RJ; Sloan J; Fu H; Tsai M; Stabler S; Allen R; Kaestner KH; Kazazian HH; Venditti CP
    BMC Med Genet; 2007 Oct; 8():64. PubMed ID: 17937813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.
    Chandler RJ; Venditti CP
    J Inherit Metab Dis; 2024 Jan; 47(1):63-79. PubMed ID: 37530705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.
    Manoli I; Sysol JR; Epping MW; Li L; Wang C; Sloan JL; Pass A; Gagné J; Ktena YP; Li L; Trivedi NS; Ouattara B; Zerfas PM; Hoffmann V; Abu-Asab M; Tsokos MG; Kleiner DE; Garone C; Cusmano-Ozog K; Enns GM; Vernon HJ; Andersson HC; Grunewald S; Elkahloun AG; Girard CL; Schnermann J; DiMauro S; Andres-Mateos E; Vandenberghe LH; Chandler RJ; Venditti CP
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications.
    Haijes HA; Jans JJM; Tas SY; Verhoeven-Duif NM; van Hasselt PM
    J Inherit Metab Dis; 2019 Sep; 42(5):730-744. PubMed ID: 31119747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.